Literature DB >> 20934569

Prevalence and characteristics of patients with clinical improvement but not significant left ventricular reverse remodeling after cardiac resynchronization therapy.

Dominique Auger1, Rutger J van Bommel, Matteo Bertini, Victoria Delgado, Arnold C T Ng, See Hooi Ewe, Miriam Shanks, Nina Ajmone Marsan, Eline A Q Mooyaart, Tomasz Witkowski, Don Poldermans, Martin J Schalij, Jeroen J Bax.   

Abstract

BACKGROUND: Although most patients who improve in clinical status after cardiac resynchronization therapy (CRT) also show a significant left ventricular (LV) reverse remodeling, some patients do not show echocardiographic improvement. The aim of the present study was to evaluate the degree of agreement between clinical and echocardiographic response to CRT in a large cohort of heart failure patients, and to evaluate the characteristics of patients with clinical response but without echocardiographic response.
METHODS: In 440 consecutive heart failure patients (mean age 66 ± 11 years, 81% men) treated with CRT, agreement between clinical and echocardiographic responses at 6 months of follow-up were evaluated. The combined clinical response was defined as: ≥1-point New York Heart Association functional class improvement or ≥15% increase in 6-minute walk test. Echocardiographic response was defined by a reduction in LV end-systolic volume (LVESV) ≥15%.
RESULTS: At 6 months of follow-up, clinical response was observed in 84% (n = 370) of the patients. Significant reduction in LVESV was noted in 63% (n = 276). The majority of patients who improved clinically did show LV reverse remodeling (72%, n = 268). Importantly, 28% (n = 102) of patients who improved clinically did not show significant LV reverse remodeling. The patients with clinical response but without echocardiographic response had more often ischemic heart failure as compared to patients with positive clinical and echocardiographic response (69.6% vs 57.5%; P = .021). Moreover, patients with such discordant responses had more narrow QRS complex (148 ± 31 vs 159 ± 31 milliseconds; P = .004), and showed less LV dyssynchrony than patients with concordant positive responses (90 ± 77 vs 171 ± 105 milliseconds; P < .001).
CONCLUSIONS: Although there is a good concordance between echocardiographic and clinical response to CRT, up to 28% of the population experienced clinical response without significant LV reverse remodeling. Subjects with such discrepant responses have more frequently ischemic heart failure and show more narrow QRS complex and less LV dyssynchrony than patients with both clinical and echocardiographic response.
Copyright © 2010 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20934569     DOI: 10.1016/j.ahj.2010.07.016

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  8 in total

Review 1.  Sex differences in device therapy for heart failure: utilization, outcomes, and adverse events.

Authors:  Naomi D Herz; Joseph Engeda; Robbert Zusterzeel; William E Sanders; Kathryn M O'Callaghan; David G Strauss; Samantha B Jacobs; Kimberly A Selzman; Ileana L Piña; Daniel A Caños
Journal:  J Womens Health (Larchmt)       Date:  2015-03-20       Impact factor: 2.681

2.  Effect of cardiac resynchronization therapy on cardiotrophin-1 circulating levels in patients with heart failure.

Authors:  Giuseppe Limongelli; Teo Roselli; Giuseppe Pacileo; Paolo Calabró; Valeria Maddaloni; Daniele Masarone; Lucia Riegler; Rita Gravino; Raffaella Scarafile; Gemma Salerno; Tiziana Miele; Antonello D'Andrea; Lucio Santangelo; Massimo Romano; Giovanni Di Salvo; Maria Giovanna Russo; Raffaele Calabró
Journal:  Intern Emerg Med       Date:  2011-12-17       Impact factor: 3.397

3.  Visualization and simulated surgery of the left ventricle in the virtual pathological heart of the Virtual Physiological Human.

Authors:  N J B McFarlane; X Lin; Y Zhao; G J Clapworthy; F Dong; A Redaelli; O Parodi; D Testi
Journal:  Interface Focus       Date:  2011-03-30       Impact factor: 3.906

4.  Association between resolution of fragmented QRS and response to cardiac resynchronization therapy.

Authors:  Umut Celikyurt; Kurtulus Karauzum; Tayfun Sahin; Aysen Agacdiken; Ahmet Vural; Dilek Ural
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-07-07       Impact factor: 1.468

5.  Relationship between fragmented QRS and response to cardiac resynchronization therapy.

Authors:  Umut Celikyurt; Aysen Agacdiken; Tayfun Sahin; Neslihan Al; Ahmet Vural; Dilek Ural
Journal:  J Interv Card Electrophysiol       Date:  2012-08-29       Impact factor: 1.900

6.  Improvement in left ventricular intrinsic dyssynchrony with cardiac resynchronization therapy.

Authors:  Serdar Bozyel; Ayşen Ağaçdiken Ağır; Tayfun Şahin; Umut Çelikyurt; Müjdat Aktaş; Onur Argan; İrem Yılmaz; Kurtuluş Karaüzüm; Emir Derviş; Ahmet Vural; Dilek Ural
Journal:  Anatol J Cardiol       Date:  2017-03-03       Impact factor: 1.596

7.  Neutrophil-to-lymphocyte ratio predicts response to cardiac resynchronization therapy.

Authors:  Aysen Agacdiken; Umut Celikyurt; Tayfun Sahin; Kurtulus Karauzum; Ahmet Vural; Dilek Ural
Journal:  Med Sci Monit       Date:  2013-05-17

8.  Predictors of positive response to cardiac resynchronization therapy.

Authors:  Diana Rinkuniene; Silvija Bucyte; Kristina Ceseviciute; Silvijus Abramavicius; Kristina Baronaite-Dudoniene; Jolanta Laukaitiene; Tomas Kazakevicius; Vytautas Zabiela; Vytautas Sileikis; Aras Puodziukynas; Renaldas Jurkevicius
Journal:  BMC Cardiovasc Disord       Date:  2014-04-29       Impact factor: 2.298

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.